Evidence map›Paper›PMID 30980333›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

The Galaxy Platform for Reproducible Affinity Proteomic Mass Spectrometry Data Analysis.

Paul A Stewart, Brent M Kuenzi, Subina Mehta, Praveen Kumar, James E Johnson, Pratik Jagtap, Timothy J Griffin, Eric B Haura

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Paul A StewartDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA. Paul.Stewart@moffitt.org.
Brent M KuenziDepartment of Drug Discovery, Moffitt Cancer Center, Tampa, FL, USA.
Subina MehtaDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Praveen KumarDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
James E JohnsonMinnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.
Pratik JagtapDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Timothy J GriffinDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Eric B HauraDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA.
University of Minnesota · USMoffitt Cancer Center · USUniversity of South Florida · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Expanding multiplexed kinase biosensor analysis to SWATH-MS (Part 2 of 2)U24CA199347 · NCI · UNIVERSITY OF MINNESOTA · PI GRIFFIN, TIMOTHY J. · 2016 to 2019
$2.4M
New therapeutic opportunities from mining polypharmacology mechanisms of ceritinib in ALK-negative non-small cell lung cancerF99CA212456 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KUENZI, BRENT · 2016 to 2017
$70k
NCI NIH HHS F99 CA212456NCI NIH HHS P30 CA076292NCI NIH HHS U24 CA199347
6 · The paper itself

Abstract

Affinity proteomics (AP-MS) is growing in importance for characterizing protein-protein interactions (PPIs) in the form of protein complexes and signaling networks. The AP-MS approach necessitates several different software tools, integrated into reproducible and accessible workflows. However, if the scientist (e.g., a bench biologist) lacks a computational background, then managing large AP-MS datasets can be challenging, manually formatting AP-MS data for input into analysis software can be error-prone, and data visualization involving dozens of variables can be laborious. One solution to address these issues is Galaxy, an open source and web-based platform for developing and deploying user-friendly computational pipelines or workflows. Here, we describe a Galaxy-based platform enabling AP-MS analysis. This platform enables researchers with no prior computational experience to begin with data from a mass spectrometer (e.g., peaklists in mzML format) and perform peak processing, database searching, assignment of interaction confidence scores, and data visualization with a few clicks of a mouse. We provide sample data and a sample workflow with step-by-step instructions to quickly acquaint users with the process.

Indexed as

Chromatography, AffinityMass SpectrometryProteomicsSoftwareComputational BiologyData AnalysisDatabases, ProteinProtein Interaction MappingWeb BrowserAffinity proteomicsAffinity purificationAP-MSAPOSTLGalaxy-P

Identifiers

PMID30980333
PMCPMC7787333
OpenAlexW2936638841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.